Engene Holdings Inc Share Price

NASDAQ: ENGN

Small Cap

$5.97

+0.26

(+4.55%)

as on September 16, 2025 at 1:28 am IST

$₹

Engene Holdings Inc Stock Performance

as on September 16, 2025 at 1:28 am IST

Day's Low
Day's High
$5.61
Day's Price Range
$6.01
$5.97
6.03%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
$2.65
52-Week Price Range
$11
$5.97
55.61%
Downside
84.25%
Upside

Engene Holdings Inc share price movements today

Previous Close: $5.71
Open: $5.75
Volume: 217.4K
Day's Low - High: $5.61 - $6.01
52 Week Low - High: $2.65 - $11

Engene Holdings Inc Historical Returns

1 Month Return: + 55.16 %
3 Month Return: + 71.47 %
1 Year Return: -14.65 %
3 Year Return: 0 %
5 Year Return: 0 %

Engene Holdings Inc Stock Fundamentals & Key Indicators

Check Engene Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$291.8M

EPS (TTM)

-2.1367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-101.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

536100000.00%

Engene Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Engene Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Engene Holdings Inc	BUY	$291.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Engene Holdings Inc Stock including INR - Dollar returns

The Engene Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Engene Holdings Inc investment value today

Current value as on today

₹94,223

Returns

₹5,777

(-5.78%)

Returns from Engene Holdings Inc Stock

₹10,762 (-10.76%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Engene Holdings Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Engene Holdings Inc. Average target price of $21.3

Engene Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Engene Holdings Inc.

What analysts predicted

71.97%UPSIDE

Target Price

$21.3

Current Price

$5.97

Analyzed by

11 Analysts

Target

$21.30

Engene Holdings Inc target price $21.3, a slight upside of 71.97% compared to current price of $5.97. According to 11 analysts rating.

Engene Holdings Inc Stock's Interest Amongst Investors

Search interest for Engene Holdings Inc Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:133% versus previous 30 day period

Engene Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Dec 2023	Jan 2024	Mar 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Total Revenue	-	-	-	-	-	-	0	-	-
Gross Profit	-	-	0	-	0	0	0	0	0
Operating Income	-10	-	-10	-	-17	-16	-17	-26	27
EBITDA	-81	-	-10	-	-14	-13	-14	-23	-24
Interest Expense	1	-	0	-	0	0	0	0	0
Depreciation	0	-	0	-	0	0	0	0	0
Income Before Tax	-82	-	-10	-	-14	-14	-15	-24	25
Income Tax Expense	-51	-	0	-	0	0	0	0	0
Net Income	-82	-10	-10	-14	-14	-14	-15	-24	25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3187.29%	0.00%	0.00%

Engene Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Oct 2020	Dec 2020	Oct 2021	Dec 2021	Oct 2022	Dec 2022	Oct 2023	Dec 2023	Oct 2024
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	0	-	0
Operating Income	-13	-	-15	-	-1	-	-26	-	62
EBITDA	-12	-	0	-	0	-	-94	-	-52
Interest Expense	3	-	5	-	1	-	4	-	2
Depreciation	0	-	0	-	0	-	0	-	0
Income Before Tax	-15	-	-23	-	0	-	-99	-	55
Income Tax Expense	4	-	4	-	0	-	0	-	0
Net Income	-15	-15	-23	-23	0	-24	-99	-99	-55
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Engene Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jul 2023	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025
Net Income	-4	-82	-10	-14	-14	-15	-24	-25	-28
Operating Cash Flow	-7	-6	-7	-14	-7	-19	-25	-22	-25
Investing Cash Flow	0	0	0	0	0	-125	-84	17	1
Financing Cash Flow	27	50	12	193	0	60	0	0	0
Change in Cash	20	43	4	179	-7	-84	-110	-4	-24

Engene Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Oct 2021	Oct 2022	Oct 2023	Oct 2024
Net Income	-23	-24	-99	-55
Operating Cash Flow	-15	-17	-24	-48
Investing Cash Flow	0	0	0	-125
Financing Cash Flow	22	27	86	265
Change in Cash	6	9	61	91

Insights on Engene Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ENGN stock has moved up by 55.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 88.2%

About Engene Holdings Inc

enGene Holdings Inc. is a clinical-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The Company’s lead program is detalimogene voraplasmid, (detalimogene) for patients with non-muscle invasive bladder cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase II study, which includes a cohort studying detalimogene in Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (Cis). Detalimogene is being developed through its proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. The Company is developing non-viral genetic medicines based on its DDX gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Organisation	Engene Holdings Inc
Headquarters	4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
CEO	Mr. Ronald H. W. Cooper
E-voting on shares	Click here to vote

Key Management of Engene Holdings Inc

Name	Title
Ms. Tara Place M.B.A.	Senior VP of Human Resources
Dr. Anthony T. Cheung Ph.D.	Co-Founder & Chief Scientific Officer
Mr. John C. Brown D.Sc., FRSC, Ph.D.	Co-Founder and Member of Scientific Advisory Board
Dr. Alexander Nichols Ph.D.	Chief Strategy & Operations Officer
Ms. Joan Connolly	Chief Technology Officer
Ms. Jill Buck	Chief Development Officer
Mr. Ronald H. W. Cooper	President, CEO & Director
Mr. David Ryan Daws	CFO & Head of Business Development
Mr. Lee G. Giguere	Chief Legal Officer & Corporate Secretary
Mr. Matthew Boyd	Chief Regulatory Officer

FAQs

What is Engene Holdings Inc share price today?

Engene Holdings Inc share price today is $5.97 as on September 16, 2025 at 1:28 am IST at the close of the market. Engene Holdings Inc share today touched a day high of $6.01 and a low of $5.61.

What is the 52 week high and 52 week low for Engene Holdings Inc share?

Engene Holdings Inc share touched a 52 week high of $11 on October 17, 2024 and a 52 week low of $2.65 on May 13, 2025. Engene Holdings Inc stock price today i.e. September 16, 2025 at 1:28 am IST is closed at $5.97,which is 45.73% down from its 52 week high and 125.28% up from its 52 week low.

What is Engene Holdings Inc's market capitalisation today?

Engene Holdings Inc market capitalisation is $0.00T as on September 16, 2025 at 1:28 am IST.

How to invest in Engene Holdings Inc Stock (ENGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Engene Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Engene Holdings Inc Shares that will get you 0.2513 shares as per Engene Holdings Inc share price of $5.97 per share as on September 16, 2025 at 1:28 am IST.

What is the minimum amount required to buy Engene Holdings Inc Stock (ENGN) from India?

Indian investors can start investing in Engene Holdings Inc (ENGN) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 7:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Engene Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 7:42 am IST). Based on Engene Holdings Inc share’s latest price of $5.97 as on September 16, 2025 at 1:28 am IST, you will get 1.6750 shares of Engene Holdings Inc. Learn more about fractional shares .